These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [All mortality by cause of death. The challenge of coronary prevention]. Fernández-Cruz A Rev Esp Cardiol; 1998; 51 Suppl 6():23-9. PubMed ID: 10050141 [TBL] [Abstract][Full Text] [Related]
5. Cholesterol and violent behavior. Santiago JM; Dalen JE Arch Intern Med; 1994 Jun; 154(12):1317-21. PubMed ID: 8002683 [TBL] [Abstract][Full Text] [Related]
6. Deaths due to accidents and violence in two recent trials of cholesterol-lowering drugs. Wysowski DK; Gross TP Arch Intern Med; 1990 Oct; 150(10):2169-72. PubMed ID: 2222103 [TBL] [Abstract][Full Text] [Related]
7. Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease. Marchioli R; Marfisi RM; Carinci F; Tognoni G Arch Intern Med; 1996 Jun; 156(11):1158-72. PubMed ID: 8639010 [TBL] [Abstract][Full Text] [Related]
8. Prevention of coronary heart disease through cholesterol reduction. Grundy SM Am Fam Physician; 1997 May; 55(6):2250-8. PubMed ID: 9149652 [TBL] [Abstract][Full Text] [Related]
9. [The role of cholesterol-lowering drugs in prevention of coronary heart disease]. Skałuba Z; Undas R Przegl Lek; 1998; 55(7-8):382-7. PubMed ID: 10021881 [TBL] [Abstract][Full Text] [Related]
10. Ezetimibe: new preparation. A cholesterol-lowering drug with no clinical advantage. Prescrire Int; 2004 Oct; 13(73):176-9. PubMed ID: 15499698 [TBL] [Abstract][Full Text] [Related]
11. Cholesterol reduction therapy: a double-edged knife. Ong HT Med J Malaysia; 1993 Jun; 48(2):107-12. PubMed ID: 8350783 [TBL] [Abstract][Full Text] [Related]
12. [Statins in primary prevention of coronary heart disease]. Paulweber B Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004 [TBL] [Abstract][Full Text] [Related]
13. The benefit of cholesterol-lowering medications after coronary revascularization: a population study. Brophy JM; Brassard P; Bourgault C Am Heart J; 2005 Aug; 150(2):282-6. PubMed ID: 16086931 [TBL] [Abstract][Full Text] [Related]
14. [Lowering cholesterol: how low is low enough?]. Czuriga I; Edes I Orv Hetil; 2006 Jul; 147(29):1349-56. PubMed ID: 16941825 [TBL] [Abstract][Full Text] [Related]
16. [Hypercholesterolemia: to treat or not to treat? That is the question]. Ducobu J Rev Med Brux; 1994; 15(3):124-31. PubMed ID: 8066357 [TBL] [Abstract][Full Text] [Related]
18. [Therapy and prevention of coronary heart diseases through lowering of the serum cholesterol levels; third consensus 'Cholesterol'. Consensus Working Group, CBO]. Simoons ML; Casparie AF Ned Tijdschr Geneeskd; 1998 Sep; 142(38):2096-101. PubMed ID: 9856223 [TBL] [Abstract][Full Text] [Related]
19. Cholesterol lowering, sudden cardiac death and mortality. de Lorgeril M; Salen P Scand Cardiovasc J; 2008 Aug; 42(4):264-7. PubMed ID: 18615354 [TBL] [Abstract][Full Text] [Related]
20. Cholesterol lowering and mortality: time for a new paradigm? de Lorgeril M; Salen P Nutr Metab Cardiovasc Dis; 2006 Sep; 16(6):387-90. PubMed ID: 16875805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]